Information  X 
Enter a valid email address

Assura plc (AGR)


Monday 11 April, 2022

Assura plc

Scrip Dividend Declaration

RNS Number : 6845H
Assura PLC
11 April 2022

11 April 2022

Assura plc

Scrip Dividend Declaration

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that, pursuant to its Scrip Dividend Scheme and in response to the scrip dividend alternative for the quarterly interim dividend payable on 13 April 2022 (the "Scrip Dividend Alternative"), elections were received in respect of 1 per cent. of the Company's ordinary shares in issue as at the record date of 11 March 2022.

Electing shareholders will receive ordinary shares in the Company ("Shares") in lieu of cash in respect of this dividend and, accordingly 317,384 Shares (the "New Shares") will be issued by the Company to such shareholders.

Application has therefore been made for the admission of the New Shares to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 13 April 2022.

Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 2,952,008,560 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,952,008,560.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism ( ).

This interim dividend is 100% Property Income Distribution ("PID").

Forms to register for gross PIDs (on future interim dividends) are available on the Company's website. Please click here for PID Forms .

- ENDS -

For more information, please contact:


Assura plc


Tel: 01925 945354

Orla Ball, Company Secretary

David Purcell, Head of Investor Relations


Email: [email protected]

Finsbury Glover Hering

Gordon Simpson
James Thompson

Tel: 0207 251 3801

Email: [email protected]


Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2021, Assura's property portfolio was valued at 2,595 million.

Further information is available at

* EPRA is a registered trademark of the European Public Real Estate Association

Assura plc LEI code: 21380026T19N2Y52XF72

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t